NCT01607476View on ClinicalTrials.gov

Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

C11 PiB

One time intravenous administration of 8-22 millicurie (mCi) C11 PiB

DRUG

F18 Flutametamol

One time intravenous administration of 3-7 mCi F18 Flutametamol.

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER